Thu, 3 August 2017
Years after the downturn started, oil majors relent and believe $50 oil is the new reality. Are they right? |
Wed, 2 August 2017
How Celgene and Gilead Sciences results are fueling their stock prices this quarter, plus Merck’s Keytruda closes the sales gap between it and Bristol-Myers Squibb’s Opdivo.
|
Tue, 1 August 2017
We break down the latest developments in the consumer-retail sector, including Amazon earnings, the $1.4 billion Jimmy Choo buyout, and the turnaround prospects for Target. Get $25 off your first purchase at http://bombfell.com/fool. |